Skip to content

Strength, Pain and Function in Operation Iraqi Freedom/Operation Enduring Freedom Amputees: A Nurse-Managed Program

Strength, Pain and Function in Operation Iraqi Freedom/Operation Enduring Freedom Amputees: A Nurse-Managed Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00942890
Enrollment
44
Registered
2009-07-21
Start date
2009-04-30
Completion date
2015-08-31
Last updated
2018-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Amputation

Keywords

Case Management, Amputation, Muscle strength, phantom limb pain

Brief summary

The purpose of this randomized control study is to determine if administering neuromuscular electrical stimulation (NMES) to the thigh muscles of a below the knee amputee is more effective than the current standard of care in preserving thigh muscle strength. In addition, this study will examine the NMES treatment effects on the participant's gait, quality of life, functional performance of standing, walking, and stair climbing, and symptoms associated with residual and phantom limb pain. The primary aim is to compare NMES plus standard rehabilitation (treatment group) to the standard rehabilitation (control group) by measuring lower extremity muscle strength. The secondary aims are to compare NMES treatment group to the control group by measuring Quality of Life (QOL) and the symptoms associated with residual & phantom limb pain. In addition to the specific aims, this study will also examine the two groups for functional performance and gait patterns after prosthetic fitting.

Detailed description

Traumatic amputation is one of the major injuries seen as a result of Operation Iraqi and Enduring Freedom with the majority being single trans-tibial amputations (TTA). TTA experience significant reductions in thigh muscle strength of the amputated limb during the first year after amputation. The residual limb is less active in daily functions of standing and walking, resulting in progressive atrophy of the quadriceps muscles in terms of a decrease in thigh diameter which is estimated at 25% of pre-amputation diameter. An intervention that may be useful in TTA rehabilitation is neuromuscular electrical stimulation (NMES). The overall objectives of this study is to test two different approaches to prosthetic rehabilitation as potential treatments for improving muscle strength, pain and functional performance of daily activities in military personnel with TTA. Our central hypothesis is that a Nurse Managed NMES rehabilitation program will have greater improvements in muscle strength and pain as compared to the standard rehabilitation protocol alone. The rationale for this study is that NMES could have an additive effect to the Walter Reed Army Medical Center (WRAMC) standard of care program with greater improvements in muscle strength thus enhancing the performance of daily activities, Quality of Life (QOL), and decreasing disability. Such outcomes will ultimately result in decreased economic costs, accelerated rehabilitation, and potentially increase the possibility of these warriors returning to duty. The specific aims are to test Nurse Managed NMES relative to standard rehabilitation by comparing: (1) Lower extremity muscle strength; (2) QOL; and (3) Symptoms associated with phantom pain. In addition to the above aims, specific aims for the post prosthetic phase of the intervention are to compare the two groups for (4) functional performance of daily activities. After pre-testing, participants aged 18 to 55 yrs with a traumatic TTA will be randomly assigned to either the 1) Nurse Managed NMES rehabilitation program (n=30); or 2) WRAMC Amputee Protocol (n=30). Those in the NMES group will receive 12 weeks of electrical muscle stimulation 15 min/day, 5 days a week for 12 weeks. Both groups will receive the standard 12-week Walter Reed Army Medical Center rehabilitation protocol. Generalized Estimating Equation methods will be used to build regression models for statistical analysis of the longitudinal data. The significance of this research is that Nurse Managed NMES may be very important for accelerating the rehabilitation of amputees so they can achieve functional independence and regain lost muscle strength in preparation for return to duty.

Interventions

DEVICENMES (EMPI 300PV stimulator) plus standard of care

In addition to the standard rehabilitation, the NMES treatment group will receive neuromuscular electrical stimulation to the quadriceps muscle of the residual and intact limb. The name of the NMES device is EMPI 300PV. NMES training will consist of performing 15 to 20 minute stimulation sessions with a 5-minute patient treatment log, 5 times per week for 12 weeks. During each training session, 15 NMES contractions per leg will be completed. Each contraction will be elicited by an electrical impulse (300PV) generated by a battery-operated device. This will be performed at home.

BEHAVIORALTMARP standard of care

The usual care is 12 weeks of the Traditional Military Amputee Rehabilitation Program (TMARP). TMARP training starts 1week after surgical closure of the residual limb. Physical Therapy performs Pre-Prosthetic Training for about 6 weeks, preparing for the prosthetic. After pre-prosthetic training, patients are fitted with their prosthetic leg and began post-prosthetic training with PT. The training focus is lower limb prosthetic proficient in ambulation.

Sponsors

Walter Reed National Military Medical Center
CollaboratorFED
United States Naval Medical Center, San Diego
CollaboratorFED
University of Tennessee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Unilateral trans-tibial amputee; 2. Military service member at the time of injury (Active Duty, Reserves or National Guard); 3. Age ≥18 and ≤55 years; and 4. Able to provide freely given informed consent.

Exclusion criteria

1. A significant co-morbid medical condition (such as severe uncontrolled hypertension (over 160/100 mmHg) or neurological disorders such as epilepsy) where NMES strength training is contraindicated and/or participation would pose a safety threat or impair their ability to participate; 2. Unable to speak and read English; 3. Implanted cardiac pacemaker or defibrillator; 4. Vision impairment where participant is classified as legally blind (we define legally blind both clinically and functionally. Clinically, it is central visual acuity of 20/200 or less in the better eye with corrective glasses. Functionally, the participant is not able to see the digital numbers on the NMES device with corrective glasses); 5. Unwillingness to accept random assignment; 6. Currently participating in another research study with an intervention that would potentially confound the outcome variables of this study (we will also instruct participants that joining a study after being enrolled in this protocol is also not allowed); and 7. Conflicting co-morbidities including traumatic brain injury (score \< 14 on glasgow coma scale), and a contralateral lower extremity injury that causes antalgic gait, pain \> 5/10 consistently on the contralateral limb and/or a grade of \< 4+/5 in lower extremity.

Design outcomes

Primary

MeasureTime frameDescription
Lower Extremity Mobility-Chair Rise6, 12 wksMobility was measured by the number of stands during the 30-second chair rise test.
Lower Extremity Mobility- Up and Go6, 12 wksMobility was measured by the time to complete an up and go test.
Lower Extremity Mobility- Stair Climb6, 12 wksMobility was measured by the time to complete a timed stair climb.
Lower Extremity Muscle Strength- Extension0, 3, 6, 9, 12 wksMuscle strength was measured with a handheld dynamometer for extensor knee strength of the residual and intact limb.
Lower Extremity Muscle Strength- Flexion0, 3, 6, 9, 12 wksMuscle strength was measured with a handheld dynamometer for extensor and flexor knee strength of the residual and intact limb.
Lower Extremity Mobility-Distance6, 12 wksMobility was measured by the distance walked in 2 minutes.

Secondary

MeasureTime frameDescription
Pain Interference0, 3, 6, 9, 12 wksPain interference was measured as how pain hindered daily activities: general activities, walking, work, mood, enjoyment of life, relations with others, and sleep using the Brief Pain Inventory. Participants rate each item on a scale from 0-10 (0=does not interfere; 10=completely interferes). The interference score represents the mean of the seven items.
Pain Severity0, 3, 6, 9, 12 wksPain severity was measured using a 4-item subscale of the Brief Pain Inventory. Pain is assessed at its worst, least, average, and current level. Scores range from 0 (no pain) to 10 (pain, as bad as one can imagine). A mean pain score was calculated from the four items.

Countries

United States

Participant flow

Pre-assignment details

There was a total of 44 participants.

Participants by arm

ArmCount
Standard Rehabilitation Protocol
The usual care is 12 weeks of the Traditional Military Amputee Rehabilitation Program (TMARP). TMARP training starts 1week after surgical closure of the residual limb. Physical Therapy performs Pre-Prosthetic Training for about 6 weeks. After pre-prosthetic training, patients are fitted with their prosthetic leg and began post-prosthetic training with PT. The training focus is lower limb prosthetic proficient in ambulation.
21
NMES Plus Standard Rehabilitation Protocol
NMES (EMPI 300PV stimulator) plus TMARP standard of care intervention. NMES is to the quadriceps muscle of the residual and intact limb plus rehabilitation. Therapy is 12-wks of NMES home training w/ the EMPI 300PV muscle stimulator. Participants perform training at home for 5days/wk; sessions consisted of 15 to 20 min. of NMES to each leg eliciting15 contractions/leg (10 seconds on:50 seconds off), plus a 5-minute patient treatment log, 5x/wk for 12-wks. Each contraction will be elicited by an electrical impulse generated by a battery-operated device. Two 3 X 5 electrodes are placed over the quadriceps muscle group. Participants will train at 30-40% of MVC during weeks 1-6, and 40-50% of MVC during weeks 7-12; incremental increases will be made at the study visits.
23
Total44

Baseline characteristics

CharacteristicNMES Plus Standard Rehabilitation ProtocolStandard Rehabilitation ProtocolTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
23 Participants21 Participants44 Participants
Age, Continuous26.5 years
STANDARD_DEVIATION 5.9
27.1 years
STANDARD_DEVIATION 6.3
26.5 years
STANDARD_DEVIATION 5.9
Region of Enrollment
United States
23 participants21 participants44 participants
Sex: Female, Male
Female
1 Participants0 Participants1 Participants
Sex: Female, Male
Male
22 Participants21 Participants43 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 23
serious
Total, serious adverse events
0 / 210 / 23

Outcome results

Primary

Lower Extremity Mobility-Chair Rise

Mobility was measured by the number of stands during the 30-second chair rise test.

Time frame: 6, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Mobility-Chair RiseWeek 618.1 Number of standsStandard Deviation 11.4
Standard Rehabilitation ProtocolLower Extremity Mobility-Chair RiseWeek 1221.7 Number of standsStandard Deviation 9.9
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility-Chair RiseWeek 615.7 Number of standsStandard Deviation 8.4
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility-Chair RiseWeek 1219.4 Number of standsStandard Deviation 9.2
Primary

Lower Extremity Mobility-Distance

Mobility was measured by the distance walked in 2 minutes.

Time frame: 6, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceUsual Pace: Week 65081 inchesStandard Deviation 2324
Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceUsual Pace: Week 125853 inchesStandard Deviation 2420
Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceFast Pace: Week 67308 inchesStandard Deviation 2557
Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceFast Pace: Week 128116 inchesStandard Deviation 2763
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceFast Pace: Week 127692 inchesStandard Deviation 2072
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceUsual Pace: Week 64452 inchesStandard Deviation 1949
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceFast Pace: Week 66369 inchesStandard Deviation 2316
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility-DistanceUsual Pace: Week 125657 inchesStandard Deviation 1919
Primary

Lower Extremity Mobility- Stair Climb

Mobility was measured by the time to complete a timed stair climb.

Time frame: 6, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Mobility- Stair ClimbWeek 67.8 SecondsStandard Deviation 3.8
Standard Rehabilitation ProtocolLower Extremity Mobility- Stair ClimbWeek 124.7 SecondsStandard Deviation 3.3
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility- Stair ClimbWeek 67.5 SecondsStandard Deviation 4.4
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility- Stair ClimbWeek 125.6 SecondsStandard Deviation 4
Primary

Lower Extremity Mobility- Up and Go

Mobility was measured by the time to complete an up and go test.

Time frame: 6, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Mobility- Up and GoWeek 126.3 SecondsStandard Deviation 3.5
Standard Rehabilitation ProtocolLower Extremity Mobility- Up and GoWeek 67.3 SecondsStandard Deviation 3.9
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility- Up and GoWeek 67.7 SecondsStandard Deviation 4.8
NMES Plus Standard Rehabilitation ProtocolLower Extremity Mobility- Up and GoWeek 127.1 SecondsStandard Deviation 4.4
Primary

Lower Extremity Muscle Strength- Extension

Muscle strength was measured with a handheld dynamometer for extensor knee strength of the residual and intact limb.

Time frame: 0, 3, 6, 9, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 024.5 KilogramsStandard Deviation 10.7
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 327.6 KilogramsStandard Deviation 12.5
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 633.8 KilogramsStandard Deviation 17.3
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 935.7 KilogramsStandard Deviation 14
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 1236.1 KilogramsStandard Deviation 15.4
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 045.7 KilogramsStandard Deviation 23.8
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 345.2 KilogramsStandard Deviation 24.3
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 645.0 KilogramsStandard Deviation 19.5
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 946.0 KilogramsStandard Deviation 16.7
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 1249.0 KilogramsStandard Deviation 20.7
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 645.2 KilogramsStandard Deviation 13.7
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 026.4 KilogramsStandard Deviation 13.4
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 045.4 KilogramsStandard Deviation 17.6
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 334.1 KilogramsStandard Deviation 12.7
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 1251.8 KilogramsStandard Deviation 16.6
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 636.9 KilogramsStandard Deviation 12.6
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 341.4 KilogramsStandard Deviation 16.1
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 939.1 KilogramsStandard Deviation 16.5
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionIntact Limb: Week 945.7 KilogramsStandard Deviation 16.1
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionResidual Limb: Week 1242.8 KilogramsStandard Deviation 14.8
p-value: <0.05Mixed Models Analysis
Primary

Lower Extremity Muscle Strength- Flexion

Muscle strength was measured with a handheld dynamometer for extensor and flexor knee strength of the residual and intact limb.

Time frame: 0, 3, 6, 9, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 014.8 KilogramsStandard Deviation 8.5
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 314.8 KilogramsStandard Deviation 7.4
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 616.8 KilogramsStandard Deviation 7.3
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 918.4 KilogramsStandard Deviation 7.5
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 1219.5 KilogramsStandard Deviation 8.4
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 025.4 KilogramsStandard Deviation 7.1
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 327.1 KilogramsStandard Deviation 10.2
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 626.9 KilogramsStandard Deviation 10.9
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 928.8 KilogramsStandard Deviation 9.9
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 1228.8 KilogramsStandard Deviation 10.1
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 632.2 KilogramsStandard Deviation 10.3
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 014.2 KilogramsStandard Deviation 6.2
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 027.8 KilogramsStandard Deviation 10.7
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 316.7 KilogramsStandard Deviation 7
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 1229.4 KilogramsStandard Deviation 9.9
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 618.7 KilogramsStandard Deviation 6.9
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 328.7 KilogramsStandard Deviation 9.4
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 919.9 KilogramsStandard Deviation 7.6
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionIntact Limb: Week 930.9 KilogramsStandard Deviation 9.7
NMES Plus Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionResidual Limb: Week 1221.8 KilogramsStandard Deviation 6.6
Secondary

Pain Interference

Pain interference was measured as how pain hindered daily activities: general activities, walking, work, mood, enjoyment of life, relations with others, and sleep using the Brief Pain Inventory. Participants rate each item on a scale from 0-10 (0=does not interfere; 10=completely interferes). The interference score represents the mean of the seven items.

Time frame: 0, 3, 6, 9, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolPain InterferenceWeek 32.5 units on a scaleStandard Deviation 2.2
Standard Rehabilitation ProtocolPain InterferenceWeek 92.0 units on a scaleStandard Deviation 2.5
Standard Rehabilitation ProtocolPain InterferenceWeek 62.3 units on a scaleStandard Deviation 2.6
Standard Rehabilitation ProtocolPain InterferenceWeek 122.1 units on a scaleStandard Deviation 2.5
Standard Rehabilitation ProtocolPain InterferenceWeek 02.9 units on a scaleStandard Deviation 2.4
NMES Plus Standard Rehabilitation ProtocolPain InterferenceWeek 122.7 units on a scaleStandard Deviation 2.8
NMES Plus Standard Rehabilitation ProtocolPain InterferenceWeek 03.1 units on a scaleStandard Deviation 2.4
NMES Plus Standard Rehabilitation ProtocolPain InterferenceWeek 32.2 units on a scaleStandard Deviation 2
NMES Plus Standard Rehabilitation ProtocolPain InterferenceWeek 62.4 units on a scaleStandard Deviation 2.3
NMES Plus Standard Rehabilitation ProtocolPain InterferenceWeek 92.8 units on a scaleStandard Deviation 2.7
Secondary

Pain Severity

Pain severity was measured using a 4-item subscale of the Brief Pain Inventory. Pain is assessed at its worst, least, average, and current level. Scores range from 0 (no pain) to 10 (pain, as bad as one can imagine). A mean pain score was calculated from the four items.

Time frame: 0, 3, 6, 9, 12 wks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolPain SeverityWeek 32.6 units on a scaleStandard Deviation 1.4
Standard Rehabilitation ProtocolPain SeverityWeek 92.2 units on a scaleStandard Deviation 1.6
Standard Rehabilitation ProtocolPain SeverityWeek 62.2 units on a scaleStandard Deviation 1.7
Standard Rehabilitation ProtocolPain SeverityWeek 121.8 units on a scaleStandard Deviation 1.6
Standard Rehabilitation ProtocolPain SeverityWeek 02.9 units on a scaleStandard Deviation 1.5
NMES Plus Standard Rehabilitation ProtocolPain SeverityWeek 122.4 units on a scaleStandard Deviation 1.9
NMES Plus Standard Rehabilitation ProtocolPain SeverityWeek 03.3 units on a scaleStandard Deviation 1.6
NMES Plus Standard Rehabilitation ProtocolPain SeverityWeek 32.4 units on a scaleStandard Deviation 1.6
NMES Plus Standard Rehabilitation ProtocolPain SeverityWeek 62.2 units on a scaleStandard Deviation 1.4
NMES Plus Standard Rehabilitation ProtocolPain SeverityWeek 92.6 units on a scaleStandard Deviation 1.7
p-value: <0.05Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026